Creating a fully automated system for managing blood sugar in Type 1 diabetes
Advanced Artificial Pancreas Systems to Enable Fully Automated Glycemic Control in Type 1 Diabetes Mellitus
This study is working on a smart device that helps people with Type 1 diabetes manage their blood sugar automatically, so they won’t have to worry about counting carbs or announcing meals, making life a little easier for them.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Virginia NIH-funded |
| Lab location | 1 site (Charlottesville, United States) |
| Project ID | NIH-10909039 on NIH RePORTER |
What this research studies
This research aims to develop an advanced artificial pancreas system that automates blood sugar control for individuals with Type 1 diabetes. By utilizing pattern recognition technology, the system anticipates meals and adjusts insulin delivery proactively, rather than reactively. This approach seeks to eliminate the need for patients to manually announce meals or count carbohydrates, thereby simplifying diabetes management. The project includes pilot studies and a larger main study to evaluate the effectiveness of faster-acting insulin analogs in this automated system.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Type 1 diabetes who require insulin therapy.
Not a fit: Patients with Type 2 diabetes or those who do not require insulin therapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve glycemic control and reduce the burden of diabetes management for patients.
How similar studies have performed: Previous research has shown promise in automated insulin delivery systems, making this approach a continuation of successful advancements in diabetes management.
Where this research is happening
Charlottesville, United States
- University of Virginia — Charlottesville, United States (Active)
Researchers
- Principal investigator: Breton, Marc D — University of Virginia
- Study coordinator: Breton, Marc D
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.